Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - XOMA Limited (NasdaqNM:XOMA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug  8Earnings Announcement
Location
2910 Seventh Street
Berkeley, CA 94710
Phone: (510) 644-1170
Fax: (510) 644-0539
Email: investorrelations@xoma.com
Employees (last reported count): 161
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 3%
·Institutional: 49% (51% of float)
(163 institutions)
·Net Inst. Buying: 9.51M shares (+22.66%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
XOMA Ltd. is a biopharmaceutical company that develops and manufactures antibody and other protein products to treat cancer, immunological and inflammatory disorders, and infectious diseases. The Company's current product development programs include: Xanelim, efalizumab anti-CD11a; ING-1, a Human Engineered recombinant monoclonal antibody; Genimune, a Human Engineered recombinant antibody fusion protein; CI-1042, a therapeutic tumor-selective, modified adenovirus; NEUPREX (rBPI21); and Mycoprex.
More from Market Guide: Expanded Business Description

Financial Summary
XOMA develops and manufactures antibody and other protein biopharmaceuticals for disease targets that include immunological and inflammatory disorders, infectious diseases and cancer. For the three months ended 3/31/01, revenues rose 11% to $2.9 million. Net loss increased 21% to $7.6 million. Results reflect the recognition of certain license and other fee payments received from Baxter and Onyx, offset by increased product development expenses.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 5,212; after tax earnings were -6,648. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
John L. Castello, Chmn./Pres./CEO
Peter B. Davis, VP-Fin./CFO
Christopher J. Margolin, VP/Counsel/ Secy.
Clarence L. Dellio, Sr. VP.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:XOMAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$5.313
Recent Price$11.46 
52-Week High
on 27-June-2001
$17.75 
Beta1.29 
Daily Volume (3-month avg)1.38M
Daily Volume (10-day avg)631.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-1.4%
52-Week Change
relative to S&P500
+32.3%
Share-Related Items
Market Capitalization$758.6M
Shares Outstanding66.2M
Float64.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)-$0.23 
Earnings (ttm)-$0.47 
Earnings (mrq)-$0.10 
Sales (ttm)$0.15 
Cash (mrq*)$0.49 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)76.73 
Income Statements
Sales (ttm)$9.87M
EBITDA (ttm*)-$30.5M
Income available to common (ttm)-$31.0M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-63.69%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq*)3.02 
Debt/EquityN/A 
Total Cash (mrq)$71.8M
Short Interest
As of 8-Aug-2001
Shares Short1.32M
Percent of Float2.1%
Shares Short
(Prior Month)
1.92M
Short Ratio1.21 
Daily Volume1.09M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.